We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PET Imaging Could Assist Lung Cancer Treatment Planning

By MedImaging International staff writers
Posted on 18 Aug 2016
Print article
Image: A PET scan image of lung cancer (Photo courtesy of TDMU).
Image: A PET scan image of lung cancer (Photo courtesy of TDMU).
A new method of extracting big data from positron emission tomography (PET) images could help quantify lung tumors caused by a genetic mutation.

Researchers at Dana-Farber Cancer Institute (Boston, MA, USA), Brigham and Women's Hospital (BWH; Boston, AM, USA), and Harvard Medical School (HMS; Boston, MA, USA) used big data radiomics to extract information from PET images in 348 non-small cell lung cancer (NSCLC) patients. The main outcome was association between radiomic features of tumors and epidermal growth factor receptor (EGFR) and Kristen rat sarcoma viral (KRAS) genetic mutations.

The mutations were confirmed by molecular testing based on biopsies of tumor tissues, the standard of care for mutation identification. The results showed that eight radiomic features describing different aspects of the tumor, such as its shape and textures, appear to be associated with EGFR mutations, but not with KRAS. The researchers suggest that the different metabolic imaging phenotypes quantified by radiomic features may be caused by EGFR mutations, which could guide treatment. For example, 15% of patients with EGFR mutations may benefit from tyrosine kinase inhibitor (TKI) therapies.

The researchers are now assessing combining PET-based radiomic features with features derived from other imaging tests, such as computed tomography (CT) or magnetic resonance imaging (MRI), to improve the accuracy of genetic mutation identification in both lung and brain cancers. The study was presented the 58th annual meeting of the American Association of Physicists in Medicine (AAPM), held during July-August 2016 in Washington (DC, USA).

“Medical images are regularly acquired for every cancer patient that comes into our clinic for treatment, which is the case at many other cancer centers as well,” said lead author Stephen Yip, PhD, an instructor at Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women's Hospital. “This early research suggests that standard-of-care PET imaging may help guide doctors in identifying patients with EGFR mutations, potentially providing valuable information for personalized lung cancer therapy.”

Related Links:
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Harvard Medical School
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Ergonomic Advantage (EA) Line
New
Color Doppler Ultrasound System
KC20
New
Color Doppler Ultrasound System
DRE Crystal 4PX

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.